The relevance of miRNA-21 in HSV-induced inflammation in a mouse model

International Journal of Molecular Sciences

Volumn 16, Issue 4, 2015, Pages 7413-7427

  Choi, Bunsoon ^a   Kim, Hyoun Ah ^a   Suh, Chang Hee ^a   Byun, Hae Ok ^a   Jung, Ju Yang ^a   Sohn, Seonghyang ^a,b  

^a Ajou University School of Medicine   (South Korea)

^b Ajou University   (South Korea)

Author keywords

Beh et s disease; Herpes simplex virus induced inflammation; MicroRNA 21; miR 21 antagomir; Mouse model

Indexed keywords

ANTAGOMIR; CD14 ANTIGEN; COLCHICINE; INTERLEUKIN 12P35; INTERLEUKIN 16; INTERLEUKIN 17; INTERLEUKIN 6; LYMPHOCYTE ANTIGEN; MESSENGER RNA; MICRORNA 150; MICRORNA 21; PENTOXIFYLLINE; PROGRAMMED CELL DEATH PROTEIN 4; PROGRAMMED DEATH 1 RECEPTOR; RHOB GUANINE NUCLEOTIDE BINDING PROTEIN; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; INTERLEUKIN DERIVATIVE; MICRORNA; MIRN21 MICRORNA, MOUSE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHCET DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC ANALYSIS; HERPES SIMPLEX VIRUS; HUMAN; MALE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN DEFECT; UPREGULATION; ANIMAL; CASE CONTROL STUDY; DISEASE MODEL; GENETICS; HERPES SIMPLEX; INFLAMMATION; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PATHOGENICITY; SIMPLEXVIRUS; VIROLOGY;

MUS; SIMPLEXVIRUS;

ADULT; ANIMALS; BEHCET SYNDROME; CASE-CONTROL STUDIES; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FEMALE; HERPES SIMPLEX; HUMANS; INFLAMMATION; INTERLEUKINS; LEUKOCYTES, MONONUCLEAR; MALE; MICE; MICE, INBRED ICR; MICRORNAS; MIDDLE AGED; SIMPLEXVIRUS;

EID: 84927614190     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms16047413     Document Type: Article

References (59)

1. Chugh, P.; Dittmer, D.P. Potential pitfalls in microrna profiling. Wiley Interdiscip. Rev. RNA 2012, 3, 601-616.
2. Zhou, Q.; Xiao, X.; Wang, C.; Zhang, X.; Li, F.; Zhou, Y.; Kijlstra, A.; Yang, P. Decreased microRNA-155 expression in ocular Behcet's disease but not in Vogt Koyanagi Harada syndrome. Investig. Ophthalmol. Vis. Sci. 2012, 53, 5665-5674.
3. Zhou, Q.; Hou, S.; Liang, L.; Li, X.; Tan, X.; Wei, L.; Lei, B.; Kijlstra, A.; Yang, P. MicroRNA-146a and Ets-1 gene polymorphisms in ocular Behcet's disease and Vogt-Koyanagi-Harada syndrome. Ann. Rheum. Dis. 2014, 73, 170-176.
4. Lagos-Quintana, M.; Rauhut, R.; Lendeckel, W.; Tuschl, T. Identification of novel genes coding for small expressed RNAs. Science 2001, 294, 853-858.
5. Si, M.L.; Zhu, S.; Wu, H.; Lu, Z.; Wu, F.; Mo, Y.Y. MiR-21-mediated tumor growth. Oncogene 2007, 26, 2799-2803.
6. Dahiya, N.; Sherman-Baust, C.A.; Wang, T.L.; Davidson, B.; Shih Ie, M.; Zhang, Y.; Wood, W.; Becker, K.G.; Morin, P.J. MicroRNA expression and identification of putative miRNA targets in ovarian cancer. PLoS ONE 2008, 3, e2436.
7. Wang, X.; Tang, S.; Le, S.Y.; Lu, R.; Rader, J.S.; Meyers, C.; Zheng, Z.M. Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS ONE 2008, 3, e2557.
8. Chan, J.A.; Krichevsky, A.M.; Kosik, K.S. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 2005, 65, 6029-6033.
9. Cui, L.; Zhang, X.; Ye, G.; Zheng, T.; Song, H.; Deng, H.; Xiao, B.; Xia, T.; Yu, X.; Le, Y.; et al. Gastric juice microRNAs as potential biomarkers for the screening of gastric cancer. Cancer 2013, 119, 1618-1626.
10. Zhang, H.; Guo, Y.; Shang, C.; Song, Y.; Wu, B. miR-21 downregulated TCF21 to inhibit KISS1 in renal cancer. Urology 2012, 80, 1298-1302.e1.
11. Kurashige, J.; Kamohara, H.; Watanabe, M.; Tanaka, Y.; Kinoshita, K.; Saito, S.; Hiyoshi, Y.; Iwatsuki, M.; Baba, Y.; Baba, H. Serum microRNA-21 is a novel biomarker in patients with esophageal squamous cell carcinoma. J. Surg. Oncol. 2012, 106, 188-192.
12. Feng, Y.H.; Wu, C.L.; Tsao, C.J.; Chang, J.G.; Lu, P.J.; Yeh, K.T.; Uen, Y.H.; Lee, J.C.; Shiau, A.L. Deregulated expression of sprouty2 and microRNA-21 in human colon cancer: Correlation with the clinical stage of the disease. Cancer Biol. Ther. 2011, 11, 111-121.
13. Salim, H.; Akbar, N.S.; Zong, D.; Vaculova, A.H.; Lewensohn, R.; Moshfegh, A.; Viktorsson, K.; Zhivotovsky, B. miRNA-214 modulates radiotherapy response of non-small cell lung cancer cells through regulation of p38MAPK, apoptosis and senescence. Br. J. Cancer 2012, 107, 1361-1373.
14. Dillhoff, M.; Liu, J.; Frankel, W.; Croce, C.; Bloomston, M. MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival. J. Gastrointest. Surg. 2008, 12, 2171-2176.
15. Tao, Y.J.; Ren, Y.; Dong, J.B.; Zhang, L.; Cheng, J.P.; Zhou, X. Anti-sense miRNA-21 oligonucleotide inhibits Tb 3.1 human tongue squamous cell carcinoma growth in vitro (in Chinese). Zhonghua Kou Qiang Yi Xue Za Zhi 2011, 46, 79-83.
16. Zhang, H.L.; Yang, L.F.; Zhu, Y.; Yao, X.D.; Zhang, S.L.; Dai, B.; Zhu, Y.P.; Shen, Y.J.; Shi, G.H.; Ye, D.W. Serum miRNA-21: Elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy. Prostate 2011, 71, 326-331.
17. Wang, F.; Zheng, Z.; Guo, J.; Ding, X. Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor. Gynecol. Oncol. 2010, 119, 586-593.
18. Conti, A.; Aguennouz, M.; La Torre, D.; Tomasello, C.; Cardali, S.; Angileri, F.F.; Maio, F.; Cama, A.; Germano, A.; Vita, G.; et al. miR-21 and 221 upregulation and miR-181b downregulation in human grade II-IV astrocytic tumors. J. Neurooncol. 2009, 93, 325-332.
19. Lawrie, C.H.; Soneji, S.; Marafioti, T.; Cooper, C.D.; Palazzo, S.; Paterson, J.C.; Cattan, H.; Enver, T.; Mager, R.; Boultwood, J.; et al. MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int. J. Cancer 2007, 121, 1156-1161.
20. Gibcus, J.H.; Tan, L.P.; Harms, G.; Schakel, R.N.; de Jong, D.; Blokzijl, T.; Moller, P.; Poppema, S.; Kroesen, B.J.; van den Berg, A. Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile. Neoplasia 2009, 11, 167-176.
21. Wu, H.; Neilson, J.R.; Kumar, P.; Manocha, M.; Shankar, P.; Sharp, P.A.; Manjunath, N. miRNA profiling of naive, effector and memory CD8 T cells. PLoS ONE 2007, 2, e1020.
22. Svrcek, M.; El-Murr, N.; Wanherdrick, K.; Dumont, S.; Beaugerie, L.; Cosnes, J.; Colombel, J.F.; Tiret, E.; Flejou, J.F.; Lesuffleur, T.; et al. Overexpression of microRNAs-155 and 21 targeting mismatch repair proteins in inflammatory bowel diseases. Carcinogenesis 2013, 34, 828-834.
23. Takagi, T.; Naito, Y.; Mizushima, K.; Hirata, I.; Yagi, N.; Tomatsuri, N.; Ando, T.; Oyamada, Y.; Isozaki, Y.; Hongo, H.; et al. Increased expression of microRNA in the inflamed colonic mucosa of patients with active ulcerative colitis. J. Gastroenterol. Hepatol. 2010, 25 (Suppl. 1), S129-S133.
24. Wu, F.; Zhang, S.; Dassopoulos, T.; Harris, M.L.; Bayless, T.M.; Meltzer, S.J.; Brant, S.R.; Kwon, J.H. Identification of microRNAs associated with ileal and colonic crohn's disease. Inflamm. Bowel Dis. 2010, 16, 1729-1738.
25. Sonkoly, E.; Wei, T.; Janson, P.C.; Saaf, A.; Lundeberg, L.; Tengvall-Linder, M.; Norstedt, G.; Alenius, H.; Homey, B.; Scheynius, A.; et al. MicroRNAs: Novel regulators involved in the pathogenesis of psoriasis? PLoS ONE 2007, 2, e610.
26. Moschos, S.A.; Williams, A.E.; Perry, M.M.; Birrell, M.A.; Belvisi, M.G.; Lindsay, M.A. Expression profiling in vivo demonstrates rapid changes in lung microRNA levels following lipopolysaccharide-induced inflammation but not in the anti-inflammatory action of glucocorticoids. BMC Genomics 2007, 8, doi:10.1186/1471-2164-8-240.
27. Frassanito, M.A.; Dammacco, R.; Cafforio, P.; Dammacco, F. Th1 polarization of the immune response in behcet's disease: A putative pathogenetic role of interleukin-12. Arthritis Rheumatol. 1999, 42, 1967-1974.
28. Kim, E.S.; Kim, S.W.; Moon, C.M.; Park, J.J.; Kim, T.I.; Kim, W.H.; Cheon, J.H. Interactions between IL17a, IL23r, and STAT4 polymorphisms confer susceptibility to intestinal behcet's disease in Korean population. Life Sci. 2012, 90, 740-746.
29. Remmers, E.F.; Cosan, F.; Kirino, Y.; Ombrello, M.J.; Abaci, N.; Satorius, C.; Le, J.M.; Yang, B.; Korman, B.D.; Cakiris, A.; et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with behcet's disease. Nat. Genet. 2010, 42, 698-702.
30. Mizuki, N.; Meguro, A.; Ota, M.; Ohno, S.; Shiota, T.; Kawagoe, T.; Ito, N.; Kera, J.; Okada, E.; Yatsu, K.; et al. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as behcet's disease susceptibility loci. Nat. Genet. 2010, 42, 703-706.
31. Behcet, H. Über rezidivierende, aphthöse, durch ein virus verursachte geschwüre am mund, am auge und an den genitalien (in German). Dermatol. Wochenschr. 1937, 105, 1152-1157.
32. Lee, S.; Bang, D.; Cho, Y.H.; Lee, E.S.; Sohn, S. Polymerase chain reaction reveals herpes simplex virus DNA in saliva of patients with Behcet's disease. Arch. Dermatol. Res. 1996, 288, 179-183.
33. Bang, D.; Cho, Y.H.; Choi, H.J.; Lee, S.; Sohn, S.; Lee, E.S. Detection of herpes simplex virus DNA by polymerase chain reaction in genital ulcer of patients with Behçet's disease. In Proceedings of the 7th International Conference on Behçet's Disease, Tunis, Tunisia, 10-11 October 1996; pp. 74-76.
34. Nakano, H.; Tamura, T.; Yoshimoto, T.; Yagita, H.; Miyasaka, M.; Butcher, E.C.; Nariuchi, H.; Kakiuchi, T.; Matsuzawa, A. Genetic defect in T lymphocyte-specific homing into peripheral lymph nodes. Eur. J. Immunol. 1997, 27, 215-221.
35. Sohn, S.; Lee, E.S.; Bang, D.; Lee, S. Behcet's disease-like symptoms induced by the herpes simplex virus in ICR mice. Eur. J. Dermatol. 1998, 8, 21-23.
36. Sohn, S.; Lee, E.S.; Bang, D. Learning from HSV-infected mice as a model of Behcet's disease. Clin. Exp. Rheumatol. 2012, 30, S96-S103.
37. Sohn, S.; Bang, D.; Lee, E.S.; Kwon, H.J.; Lee, S.I.; Lee, S. Experimental studies on the antiviral agent famciclovir in Behcet's disease symptoms in ICR mice. Br. J. Dermatol. 2001, 145, 799-804.
38. Yang, H.S.; Knies, J.L.; Stark, C.; Colburn, N.H. Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation. Oncogene 2003, 22, 3712-3720.
39. Frankel, L.B.; Christoffersen, N.R.; Jacobsen, A.; Lindow, M.; Krogh, A.; Lund, A.H. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J. Biol. Chem. 2008, 283, 1026-1033.
40. Connolly, E.C.; van Doorslaer, K.; Rogler, L.E.; Rogler, C.E. Overexpression of miR-21 promotes an in vitro metastatic phenotype by targeting the tumor suppressor Rhob. Mol. Cancer Res. 2010, 8, 691-700.
41. Lu, T.X.; Hartner, J.; Lim, E.J.; Fabry, V.; Mingler, M.K.; Cole, E.T.; Orkin, S.H.; Aronow, B.J.; Rothenberg, M.E. MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12/IFN-γ pathway, th1 polarization, and the severity of delayed-type hypersensitivity. J. Immunol. 2011, 187, 3362-3373.
42. Kim, T.W.; Staschke, K.; Bulek, K.; Yao, J.; Peters, K.; Oh, K.H.; Vandenburg, Y.; Xiao, H.; Qian, W.; Hamilton, T.; et al. A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity. J. Exp. Med. 2007, 204, 1025-1036.
43. Takeda, K.; Akira, S. TLR signaling pathways. Semin. Immunol. 2004, 16, 3-9.
44. Do, J.E.; Kwon, S.Y.; Park, S.; Lee, E.S. Effects of vitamin D on expression of Toll-like receptors of monocytes from patients with Behcet's disease. Rheumatology 2008, 47, 840-848.
45. Choi, B.; Lee, E.S.; Sohn, S. Vitamin D3 ameliorates herpes simplex virus-induced Behcet's disease-like inflammation in a mouse model through down-regulation of Toll-like receptors. Clin. Exp. Rheumatol. 2011, 29, S13-S19.
46. Xiao, C.; Rajewsky, K. MicroRNA control in the immune system: Basic principles. Cell 2009, 136, 26-36.
47. Lindsay, M.A. MicroRNAs and the immune response. Trends Immunol. 2008, 29, 343-351.
48. Ventura, A.; Young, A.G.; Winslow, M.M.; Lintault, L.; Meissner, A.; Erkeland, S.J.; Newman, J.; Bronson, R.T.; Crowley, D.; Stone, J.R.; et al. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 2008, 132, 875-886.
49. Koralov, S.B.; Muljo, S.A.; Galler, G.R.; Krek, A.; Chakraborty, T.; Kanellopoulou, C.; Jensen, K.; Cobb, B.S.; Merkenschlager, M.; Rajewsky, N.; et al. Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell 2008, 132, 860-874.
50. Xiao, C.; Srinivasan, L.; Calado, D.P.; Patterson, H.C.; Zhang, B.; Wang, J.; Henderson, J.M.; Kutok, J.L.; Rajewsky, K. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat. Immunol. 2008, 9, 405-414.
51. Lu, T.X.; Munitz, A.; Rothenberg, M.E. MicroRNA-21 is up-regulated in allergic airway inflammation and regulates IL-12p35 expression. J. Immunol. 2009, 182, 4994-5002.
52. Shimizu, J.; Takai, K.; Fujiwara, N.; Arimitsu, N.; Ueda, Y.; Wakisaka, S.; Yoshikawa, H.; Kaneko, F.; Suzuki, T.; Suzuki, N. Excessive CD4+ T cells co-expressing interleukin-17 and interferon-γ in patients with Behcet's disease. Clin. Exp. Immunol. 2012, 168, 68-74.
53. Chi, W.; Zhu, X.; Yang, P.; Liu, X.; Lin, X.; Zhou, H.; Huang, X.; Kijlstra, A. Upregulated IL-23 and IL-17 in Behcet patients with active uveitis. Investig. Ophthalmol. Vis. Sci. 2008, 49, 3058-3064.
54. Hatley, M.E.; Patrick, D.M.; Garcia, M.R.; Richardson, J.A.; Bassel-Duby, R.; van Rooij, E.; Olson, E.N. Modulation of K-Ras-dependent lung tumorigenesis by microRNA-21. Cancer Cell 2010, 18, 282-293.
55. Sabatel, C.; Malvaux, L.; Bovy, N.; Deroanne, C.; Lambert, V.; Gonzalez, M.L.; Colige, A.; Rakic, J.M.; Noel, A.; Martial, J.A.; et al. MicroRNA-21 exhibits antiangiogenic function by targeting Rhob expression in endothelial cells. PLoS ONE 2011, 6, e16979.
56. Iliopoulos, D.; Kavousanaki, M.; Ioannou, M.; Boumpas, D.; Verginis, P. The negative costimulatory molecule PD-1 modulates the balance between immunity and tolerance via miR-21. Eur. J. Immunol. 2011, 41, 1754-1763.
57. Merline, R.; Moreth, K.; Beckmann, J.; Nastase, M.V.; Zeng-Brouwers, J.; Tralhao, J.G.; Lemarchand, P.; Pfeilschifter, J.; Schaefer, R.M.; Iozzo, R.V.; et al. Signaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and microRNA-21. Sci. Signal. 2011, 4, doi:10.1126/scisignal.2001868.
58. Liu, C.; Yu, J.; Yu, S.; Lavker, R.M.; Cai, L.; Liu, W.; Yang, K.; He, X.; Chen, S. MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma. J. Hepatol. 2010, 53, 98-107.
59. Shim, J.; Lee, E.S.; Park, S.; Bang, D.; Sohn, S. CD4+ CD25+ regulatory T cells ameliorate Behcet's disease-like symptoms in a mouse model. Cytotherapy 2011, 13, 835-847.